nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Icatibant—BDKRB2—coronary artery disease	0.0129	1	CrCbGaD
Goserelin—GNRHR—GPCR downstream signaling—KNG1—coronary artery disease	0.000147	0.000429	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—C3—coronary artery disease	0.000147	0.000428	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—BDKRB2—coronary artery disease	0.000147	0.000428	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL12—coronary artery disease	0.000147	0.000428	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGTR1—coronary artery disease	0.000146	0.000426	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDNRB—coronary artery disease	0.000146	0.000425	CbGpPWpGaD
Goserelin—Dermatitis—Ezetimibe—coronary artery disease	0.000145	0.000225	CcSEcCtD
Goserelin—Confusional state—Ramipril—coronary artery disease	0.000145	0.000224	CcSEcCtD
Goserelin—Discomfort—Timolol—coronary artery disease	0.000145	0.000224	CcSEcCtD
Goserelin—Asthenia—Niacin—coronary artery disease	0.000144	0.000224	CcSEcCtD
Goserelin—Fatigue—Losartan—coronary artery disease	0.000144	0.000224	CcSEcCtD
Goserelin—Headache—Ezetimibe—coronary artery disease	0.000144	0.000223	CcSEcCtD
Goserelin—Malaise—Lisinopril—coronary artery disease	0.000144	0.000223	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—THBS1—coronary artery disease	0.000144	0.000419	CbGpPWpGaD
Goserelin—Oedema—Ramipril—coronary artery disease	0.000143	0.000223	CcSEcCtD
Goserelin—Anaphylactic shock—Ramipril—coronary artery disease	0.000143	0.000223	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PLCB1—coronary artery disease	0.000143	0.000419	CbGpPWpGaD
Goserelin—Dry mouth—Timolol—coronary artery disease	0.000143	0.000222	CcSEcCtD
Goserelin—Constipation—Losartan—coronary artery disease	0.000143	0.000222	CcSEcCtD
Goserelin—Pain—Losartan—coronary artery disease	0.000143	0.000222	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TLE4—coronary artery disease	0.000143	0.000417	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MEF2A—coronary artery disease	0.000143	0.000417	CbGpPWpGaD
Goserelin—Vomiting—Eplerenone—coronary artery disease	0.000143	0.000222	CcSEcCtD
Goserelin—Feeling abnormal—Furosemide—coronary artery disease	0.000143	0.000222	CcSEcCtD
Goserelin—Leukopenia—Lisinopril—coronary artery disease	0.000143	0.000221	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCL10—coronary artery disease	0.000143	0.000417	CbGpPWpGaD
Goserelin—Nausea—Fenofibrate—coronary artery disease	0.000142	0.000221	CcSEcCtD
Goserelin—Pruritus—Niacin—coronary artery disease	0.000142	0.000221	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PSMA6—coronary artery disease	0.000142	0.000415	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PSMB5—coronary artery disease	0.000142	0.000415	CbGpPWpGaD
Goserelin—Asthenia—Pravastatin—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—F2—coronary artery disease	0.000142	0.000414	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Rash—Eplerenone—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Urticaria—Perindopril—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Hypersensitivity—Trandolapril—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Dermatitis—Eplerenone—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Diarrhoea—Valsartan—coronary artery disease	0.000142	0.00022	CcSEcCtD
Goserelin—Confusional state—Timolol—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Shock—Ramipril—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Hypersensitivity—Enalapril—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Body temperature increased—Perindopril—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Abdominal pain—Perindopril—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Palpitations—Lisinopril—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Diarrhoea—Olmesartan—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Headache—Eplerenone—coronary artery disease	0.000141	0.000219	CcSEcCtD
Goserelin—Nervous system disorder—Ramipril—coronary artery disease	0.000141	0.000218	CcSEcCtD
Goserelin—Thrombocytopenia—Ramipril—coronary artery disease	0.00014	0.000218	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HTR7—coronary artery disease	0.00014	0.00041	CbGpPWpGaD
Goserelin—Oedema—Timolol—coronary artery disease	0.00014	0.000218	CcSEcCtD
Goserelin—Anaphylactic shock—Timolol—coronary artery disease	0.00014	0.000218	CcSEcCtD
Goserelin—Pruritus—Pravastatin—coronary artery disease	0.00014	0.000217	CcSEcCtD
Goserelin—Nausea—Clopidogrel—coronary artery disease	0.00014	0.000217	CcSEcCtD
Goserelin—Tachycardia—Ramipril—coronary artery disease	0.00014	0.000217	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AGT—coronary artery disease	0.000139	0.000407	CbGpPWpGaD
Goserelin—Skin disorder—Ramipril—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—Infection—Timolol—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—APOA2—coronary artery disease	0.000139	0.000407	CbGpPWpGaD
Goserelin—Vomiting—Simvastatin—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—Hypersensitivity—Telmisartan—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—Cough—Lisinopril—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—Nausea—Lovastatin—coronary artery disease	0.000139	0.000216	CcSEcCtD
Goserelin—Hyperhidrosis—Ramipril—coronary artery disease	0.000139	0.000215	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADRB2—coronary artery disease	0.000139	0.000404	CbGpPWpGaD
Goserelin—Rash—Simvastatin—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Dermatitis—Simvastatin—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Asthenia—Trandolapril—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Shock—Timolol—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Feeling abnormal—Losartan—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Urticaria—Furosemide—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—Diarrhoea—Niacin—coronary artery disease	0.000138	0.000214	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EDNRA—coronary artery disease	0.000138	0.000402	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AVPR1A—coronary artery disease	0.000138	0.000402	CbGpPWpGaD
Goserelin—Nervous system disorder—Timolol—coronary artery disease	0.000138	0.000213	CcSEcCtD
Goserelin—Asthenia—Enalapril—coronary artery disease	0.000137	0.000213	CcSEcCtD
Goserelin—Headache—Simvastatin—coronary artery disease	0.000137	0.000213	CcSEcCtD
Goserelin—Abdominal pain—Furosemide—coronary artery disease	0.000137	0.000213	CcSEcCtD
Goserelin—Body temperature increased—Furosemide—coronary artery disease	0.000137	0.000213	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRB1—coronary artery disease	0.000137	0.0004	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CYBA—coronary artery disease	0.000137	0.0004	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Losartan—coronary artery disease	0.000137	0.000212	CcSEcCtD
Goserelin—Dizziness—Valsartan—coronary artery disease	0.000137	0.000212	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCE—coronary artery disease	0.000137	0.000399	CbGpPWpGaD
Goserelin—Anorexia—Ramipril—coronary artery disease	0.000137	0.000212	CcSEcCtD
Goserelin—Nausea—Ezetimibe—coronary artery disease	0.000136	0.000212	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—DUSP6—coronary artery disease	0.000136	0.000398	CbGpPWpGaD
Goserelin—Skin disorder—Timolol—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Dizziness—Olmesartan—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Pruritus—Trandolapril—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Chest pain—Lisinopril—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Arthralgia—Lisinopril—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Myalgia—Lisinopril—coronary artery disease	0.000136	0.000211	CcSEcCtD
Goserelin—Hyperhidrosis—Timolol—coronary artery disease	0.000136	0.00021	CcSEcCtD
Goserelin—Asthenia—Telmisartan—coronary artery disease	0.000136	0.00021	CcSEcCtD
Goserelin—Pruritus—Enalapril—coronary artery disease	0.000136	0.00021	CcSEcCtD
Goserelin—Diarrhoea—Pravastatin—coronary artery disease	0.000136	0.00021	CcSEcCtD
Goserelin—Anxiety—Lisinopril—coronary artery disease	0.000135	0.00021	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000135	0.000209	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PLAT—coronary artery disease	0.000134	0.000391	CbGpPWpGaD
Goserelin—Discomfort—Lisinopril—coronary artery disease	0.000134	0.000208	CcSEcCtD
Goserelin—Hypotension—Ramipril—coronary artery disease	0.000134	0.000208	CcSEcCtD
Goserelin—Anorexia—Timolol—coronary artery disease	0.000134	0.000207	CcSEcCtD
Goserelin—Pruritus—Telmisartan—coronary artery disease	0.000134	0.000207	CcSEcCtD
Goserelin—Nausea—Eplerenone—coronary artery disease	0.000134	0.000207	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—KNG1—coronary artery disease	0.000133	0.000389	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000133	0.000389	CbGpPWpGaD
Goserelin—Dizziness—Niacin—coronary artery disease	0.000133	0.000206	CcSEcCtD
Goserelin—Urticaria—Losartan—coronary artery disease	0.000133	0.000206	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—UTS2—coronary artery disease	0.000133	0.000388	CbGpPWpGaD
Goserelin—Dry mouth—Lisinopril—coronary artery disease	0.000133	0.000206	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AGTR1—coronary artery disease	0.000133	0.000387	CbGpPWpGaD
Goserelin—Body temperature increased—Losartan—coronary artery disease	0.000132	0.000205	CcSEcCtD
Goserelin—Abdominal pain—Losartan—coronary artery disease	0.000132	0.000205	CcSEcCtD
Goserelin—Asthenia—Captopril—coronary artery disease	0.000132	0.000205	CcSEcCtD
Goserelin—Diarrhoea—Trandolapril—coronary artery disease	0.000132	0.000204	CcSEcCtD
Goserelin—Vomiting—Valsartan—coronary artery disease	0.000132	0.000204	CcSEcCtD
Goserelin—Confusional state—Lisinopril—coronary artery disease	0.000131	0.000204	CcSEcCtD
Goserelin—Diarrhoea—Enalapril—coronary artery disease	0.000131	0.000203	CcSEcCtD
Goserelin—Hypotension—Timolol—coronary artery disease	0.000131	0.000203	CcSEcCtD
Goserelin—Dizziness—Pravastatin—coronary artery disease	0.000131	0.000203	CcSEcCtD
Goserelin—Vomiting—Olmesartan—coronary artery disease	0.000131	0.000203	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000131	0.000203	CcSEcCtD
Goserelin—Rash—Valsartan—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—Dermatitis—Valsartan—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—Nausea—Simvastatin—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—Oedema—Lisinopril—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—Anaphylactic shock—Lisinopril—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NR4A1—coronary artery disease	0.00013	0.00038	CbGpPWpGaD
Goserelin—Pruritus—Captopril—coronary artery disease	0.00013	0.000202	CcSEcCtD
Goserelin—Rash—Olmesartan—coronary artery disease	0.00013	0.000201	CcSEcCtD
Goserelin—Insomnia—Ramipril—coronary artery disease	0.00013	0.000201	CcSEcCtD
Goserelin—Dermatitis—Olmesartan—coronary artery disease	0.00013	0.000201	CcSEcCtD
Goserelin—Headache—Valsartan—coronary artery disease	0.00013	0.000201	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CXCL10—coronary artery disease	0.00013	0.000378	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BDKRB2—coronary artery disease	0.000129	0.000378	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL12—coronary artery disease	0.000129	0.000378	CbGpPWpGaD
Goserelin—Diarrhoea—Telmisartan—coronary artery disease	0.000129	0.000201	CcSEcCtD
Goserelin—Infection—Lisinopril—coronary artery disease	0.000129	0.000201	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—POMC—coronary artery disease	0.000129	0.000377	CbGpPWpGaD
Goserelin—Headache—Olmesartan—coronary artery disease	0.000129	0.0002	CcSEcCtD
Goserelin—Paraesthesia—Ramipril—coronary artery disease	0.000129	0.0002	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—F2—coronary artery disease	0.000129	0.000376	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLCB3—coronary artery disease	0.000129	0.000376	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC9—coronary artery disease	0.000129	0.000376	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—P2RY12—coronary artery disease	0.000129	0.000376	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6ST—coronary artery disease	0.000128	0.000374	CbGpPWpGaD
Goserelin—Shock—Lisinopril—coronary artery disease	0.000128	0.000199	CcSEcCtD
Goserelin—Asthenia—Perindopril—coronary artery disease	0.000128	0.000199	CcSEcCtD
Goserelin—Dyspnoea—Ramipril—coronary artery disease	0.000128	0.000198	CcSEcCtD
Goserelin—Vomiting—Niacin—coronary artery disease	0.000128	0.000198	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000128	0.000198	CcSEcCtD
Goserelin—Hypersensitivity—Furosemide—coronary artery disease	0.000128	0.000198	CcSEcCtD
Goserelin—Somnolence—Ramipril—coronary artery disease	0.000128	0.000198	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CX3CR1—coronary artery disease	0.000127	0.000372	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASR—coronary artery disease	0.000127	0.000372	CbGpPWpGaD
Goserelin—Thrombocytopenia—Lisinopril—coronary artery disease	0.000127	0.000198	CcSEcCtD
Goserelin—Dizziness—Trandolapril—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—JUNB—coronary artery disease	0.000127	0.000371	CbGpPWpGaD
Goserelin—Tachycardia—Lisinopril—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—Insomnia—Timolol—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—Rash—Niacin—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—Dermatitis—Niacin—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—Dizziness—Enalapril—coronary artery disease	0.000127	0.000197	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PLCB1—coronary artery disease	0.000127	0.000369	CbGpPWpGaD
Goserelin—Skin disorder—Lisinopril—coronary artery disease	0.000126	0.000196	CcSEcCtD
Goserelin—Dyspepsia—Ramipril—coronary artery disease	0.000126	0.000196	CcSEcCtD
Goserelin—Pruritus—Perindopril—coronary artery disease	0.000126	0.000196	CcSEcCtD
Goserelin—Headache—Niacin—coronary artery disease	0.000126	0.000196	CcSEcCtD
Goserelin—Paraesthesia—Timolol—coronary artery disease	0.000126	0.000195	CcSEcCtD
Goserelin—Vomiting—Pravastatin—coronary artery disease	0.000126	0.000195	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRB2—coronary artery disease	0.000126	0.000367	CbGpPWpGaD
Goserelin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000126	0.000195	CcSEcCtD
Goserelin—Diarrhoea—Captopril—coronary artery disease	0.000126	0.000195	CcSEcCtD
Goserelin—Dyspnoea—Timolol—coronary artery disease	0.000125	0.000194	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CX3CL1—coronary artery disease	0.000125	0.000365	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB1—coronary artery disease	0.000125	0.000365	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNA12—coronary artery disease	0.000125	0.000365	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—P4HB—coronary artery disease	0.000125	0.000365	CbGpPWpGaD
Goserelin—Dizziness—Telmisartan—coronary artery disease	0.000125	0.000194	CcSEcCtD
Goserelin—Rash—Pravastatin—coronary artery disease	0.000125	0.000194	CcSEcCtD
Goserelin—Dermatitis—Pravastatin—coronary artery disease	0.000125	0.000194	CcSEcCtD
Goserelin—Decreased appetite—Ramipril—coronary artery disease	0.000125	0.000194	CcSEcCtD
Goserelin—Somnolence—Timolol—coronary artery disease	0.000125	0.000193	CcSEcCtD
Goserelin—Asthenia—Furosemide—coronary artery disease	0.000124	0.000193	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PRKCE—coronary artery disease	0.000124	0.000363	CbGpPWpGaD
Goserelin—Headache—Pravastatin—coronary artery disease	0.000124	0.000193	CcSEcCtD
Goserelin—Anorexia—Lisinopril—coronary artery disease	0.000124	0.000192	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR7—coronary artery disease	0.000124	0.000362	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDN1—coronary artery disease	0.000124	0.000361	CbGpPWpGaD
Goserelin—Fatigue—Ramipril—coronary artery disease	0.000124	0.000192	CcSEcCtD
Goserelin—Dyspepsia—Timolol—coronary artery disease	0.000123	0.000192	CcSEcCtD
Goserelin—Hypersensitivity—Losartan—coronary artery disease	0.000123	0.000191	CcSEcCtD
Goserelin—Nausea—Valsartan—coronary artery disease	0.000123	0.000191	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—coronary artery disease	0.000123	0.000359	CbGpPWpGaD
Goserelin—Pruritus—Furosemide—coronary artery disease	0.000123	0.00019	CcSEcCtD
Goserelin—Constipation—Ramipril—coronary artery disease	0.000123	0.00019	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PPP3R1—coronary artery disease	0.000123	0.000358	CbGpPWpGaD
Goserelin—Nausea—Olmesartan—coronary artery disease	0.000122	0.00019	CcSEcCtD
Goserelin—Vomiting—Trandolapril—coronary artery disease	0.000122	0.00019	CcSEcCtD
Goserelin—Diarrhoea—Perindopril—coronary artery disease	0.000122	0.000189	CcSEcCtD
Goserelin—Decreased appetite—Timolol—coronary artery disease	0.000122	0.000189	CcSEcCtD
Goserelin—Vomiting—Enalapril—coronary artery disease	0.000122	0.000189	CcSEcCtD
Goserelin—Hypotension—Lisinopril—coronary artery disease	0.000122	0.000189	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADM—coronary artery disease	0.000122	0.000355	CbGpPWpGaD
Goserelin—Dizziness—Captopril—coronary artery disease	0.000122	0.000189	CcSEcCtD
Goserelin—Rash—Trandolapril—coronary artery disease	0.000121	0.000188	CcSEcCtD
Goserelin—Dermatitis—Trandolapril—coronary artery disease	0.000121	0.000188	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CSF2—coronary artery disease	0.000121	0.000353	CbGpPWpGaD
Goserelin—Fatigue—Timolol—coronary artery disease	0.000121	0.000188	CcSEcCtD
Goserelin—Rash—Enalapril—coronary artery disease	0.000121	0.000187	CcSEcCtD
Goserelin—Dermatitis—Enalapril—coronary artery disease	0.000121	0.000187	CcSEcCtD
Goserelin—Headache—Trandolapril—coronary artery disease	0.000121	0.000187	CcSEcCtD
Goserelin—Vomiting—Telmisartan—coronary artery disease	0.00012	0.000186	CcSEcCtD
Goserelin—Asthenia—Losartan—coronary artery disease	0.00012	0.000186	CcSEcCtD
Goserelin—Headache—Enalapril—coronary artery disease	0.00012	0.000186	CcSEcCtD
Goserelin—Pain—Timolol—coronary artery disease	0.00012	0.000186	CcSEcCtD
Goserelin—Nausea—Niacin—coronary artery disease	0.000119	0.000185	CcSEcCtD
Goserelin—Rash—Telmisartan—coronary artery disease	0.000119	0.000185	CcSEcCtD
Goserelin—Dermatitis—Telmisartan—coronary artery disease	0.000119	0.000185	CcSEcCtD
Goserelin—Diarrhoea—Furosemide—coronary artery disease	0.000119	0.000184	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000119	0.000184	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PDE4B—coronary artery disease	0.000118	0.000346	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBB—coronary artery disease	0.000118	0.000346	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—coronary artery disease	0.000118	0.000346	CbGpPWpGaD
Goserelin—Pruritus—Losartan—coronary artery disease	0.000118	0.000184	CcSEcCtD
Goserelin—Headache—Telmisartan—coronary artery disease	0.000118	0.000184	CcSEcCtD
Goserelin—Feeling abnormal—Ramipril—coronary artery disease	0.000118	0.000183	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—MMP3—coronary artery disease	0.000118	0.000345	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGAV—coronary artery disease	0.000118	0.000345	CbGpPWpGaD
Goserelin—Dizziness—Perindopril—coronary artery disease	0.000118	0.000183	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000118	0.000344	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KNG1—coronary artery disease	0.000118	0.000344	CbGpPWpGaD
Goserelin—Insomnia—Lisinopril—coronary artery disease	0.000118	0.000183	CcSEcCtD
Goserelin—Nausea—Pravastatin—coronary artery disease	0.000118	0.000183	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—POMC—coronary artery disease	0.000117	0.000342	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CREB1—coronary artery disease	0.000117	0.000342	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000117	0.000182	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AGTR1—coronary artery disease	0.000117	0.000342	CbGpPWpGaD
Goserelin—Paraesthesia—Lisinopril—coronary artery disease	0.000117	0.000181	CcSEcCtD
Goserelin—Vomiting—Captopril—coronary artery disease	0.000117	0.000181	CcSEcCtD
Goserelin—Dyspnoea—Lisinopril—coronary artery disease	0.000116	0.00018	CcSEcCtD
Goserelin—Rash—Captopril—coronary artery disease	0.000116	0.00018	CcSEcCtD
Goserelin—Dermatitis—Captopril—coronary artery disease	0.000116	0.00018	CcSEcCtD
Goserelin—Somnolence—Lisinopril—coronary artery disease	0.000116	0.000179	CcSEcCtD
Goserelin—Feeling abnormal—Timolol—coronary artery disease	0.000116	0.000179	CcSEcCtD
Goserelin—Headache—Captopril—coronary artery disease	0.000115	0.000179	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL2—coronary artery disease	0.000115	0.000335	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Timolol—coronary artery disease	0.000115	0.000178	CcSEcCtD
Goserelin—Dizziness—Furosemide—coronary artery disease	0.000115	0.000178	CcSEcCtD
Goserelin—Dyspepsia—Lisinopril—coronary artery disease	0.000115	0.000178	CcSEcCtD
Goserelin—Diarrhoea—Losartan—coronary artery disease	0.000114	0.000178	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL6R—coronary artery disease	0.000114	0.000334	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL10—coronary artery disease	0.000114	0.000334	CbGpPWpGaD
Goserelin—Nausea—Trandolapril—coronary artery disease	0.000114	0.000177	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PLG—coronary artery disease	0.000114	0.000333	CbGpPWpGaD
Goserelin—Urticaria—Ramipril—coronary artery disease	0.000114	0.000177	CcSEcCtD
Goserelin—Nausea—Enalapril—coronary artery disease	0.000114	0.000177	CcSEcCtD
Goserelin—Vomiting—Perindopril—coronary artery disease	0.000113	0.000176	CcSEcCtD
Goserelin—Abdominal pain—Ramipril—coronary artery disease	0.000113	0.000176	CcSEcCtD
Goserelin—Body temperature increased—Ramipril—coronary artery disease	0.000113	0.000176	CcSEcCtD
Goserelin—Decreased appetite—Lisinopril—coronary artery disease	0.000113	0.000176	CcSEcCtD
Goserelin—Rash—Perindopril—coronary artery disease	0.000112	0.000175	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—EDN1—coronary artery disease	0.000112	0.000328	CbGpPWpGaD
Goserelin—Dermatitis—Perindopril—coronary artery disease	0.000112	0.000174	CcSEcCtD
Goserelin—Nausea—Telmisartan—coronary artery disease	0.000112	0.000174	CcSEcCtD
Goserelin—Fatigue—Lisinopril—coronary artery disease	0.000112	0.000174	CcSEcCtD
Goserelin—Headache—Perindopril—coronary artery disease	0.000112	0.000173	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCL5—coronary artery disease	0.000112	0.000326	CbGpPWpGaD
Goserelin—Urticaria—Timolol—coronary artery disease	0.000111	0.000173	CcSEcCtD
Goserelin—Pain—Lisinopril—coronary artery disease	0.000111	0.000173	CcSEcCtD
Goserelin—Constipation—Lisinopril—coronary artery disease	0.000111	0.000173	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRB2—coronary artery disease	0.000111	0.000324	CbGpPWpGaD
Goserelin—Body temperature increased—Timolol—coronary artery disease	0.000111	0.000172	CcSEcCtD
Goserelin—Abdominal pain—Timolol—coronary artery disease	0.000111	0.000172	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCD—coronary artery disease	0.000111	0.000323	CbGpPWpGaD
Goserelin—Dizziness—Losartan—coronary artery disease	0.000111	0.000172	CcSEcCtD
Goserelin—Vomiting—Furosemide—coronary artery disease	0.00011	0.000171	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CSF2—coronary artery disease	0.00011	0.000321	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCE—coronary artery disease	0.00011	0.00032	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—JAK2—coronary artery disease	0.00011	0.00032	CbGpPWpGaD
Goserelin—Rash—Furosemide—coronary artery disease	0.000109	0.00017	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SOCS1—coronary artery disease	0.000109	0.000319	CbGpPWpGaD
Goserelin—Dermatitis—Furosemide—coronary artery disease	0.000109	0.00017	CcSEcCtD
Goserelin—Nausea—Captopril—coronary artery disease	0.000109	0.000169	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—S100B—coronary artery disease	0.000109	0.000318	CbGpPWpGaD
Goserelin—Headache—Furosemide—coronary artery disease	0.000109	0.000169	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR3—coronary artery disease	0.000108	0.000316	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR2A—coronary artery disease	0.000108	0.000316	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—C3—coronary artery disease	0.000108	0.000316	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS3—coronary artery disease	0.000108	0.000315	CbGpPWpGaD
Goserelin—Feeling abnormal—Lisinopril—coronary artery disease	0.000107	0.000166	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CRK—coronary artery disease	0.000107	0.000312	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFBR2—coronary artery disease	0.000107	0.000311	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KITLG—coronary artery disease	0.000107	0.000311	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000106	0.000165	CcSEcCtD
Goserelin—Vomiting—Losartan—coronary artery disease	0.000106	0.000165	CcSEcCtD
Goserelin—Nausea—Perindopril—coronary artery disease	0.000106	0.000164	CcSEcCtD
Goserelin—Hypersensitivity—Ramipril—coronary artery disease	0.000106	0.000164	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ATP2A2—coronary artery disease	0.000106	0.000308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SH2B3—coronary artery disease	0.000106	0.000308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VWF—coronary artery disease	0.000106	0.000308	CbGpPWpGaD
Goserelin—Rash—Losartan—coronary artery disease	0.000106	0.000164	CcSEcCtD
Goserelin—Dermatitis—Losartan—coronary artery disease	0.000105	0.000164	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—APOC3—coronary artery disease	0.000105	0.000306	CbGpPWpGaD
Goserelin—Headache—Losartan—coronary artery disease	0.000105	0.000163	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—LDLR—coronary artery disease	0.000104	0.000304	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP3—coronary artery disease	0.000104	0.000304	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT5A—coronary artery disease	0.000104	0.000304	CbGpPWpGaD
Goserelin—Urticaria—Lisinopril—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—Hypersensitivity—Timolol—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—Nausea—Furosemide—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—Asthenia—Ramipril—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—Abdominal pain—Lisinopril—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—Body temperature increased—Lisinopril—coronary artery disease	0.000103	0.00016	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AGT—coronary artery disease	0.000103	0.0003	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PPP2CA—coronary artery disease	0.000102	0.000299	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL3—coronary artery disease	0.000102	0.000297	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL2—coronary artery disease	0.000102	0.000297	CbGpPWpGaD
Goserelin—Pruritus—Ramipril—coronary artery disease	0.000102	0.000158	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOB—coronary artery disease	0.000101	0.000294	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SDC1—coronary artery disease	0.000101	0.000294	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2R—coronary artery disease	0.000101	0.000294	CbGpPWpGaD
Goserelin—Asthenia—Timolol—coronary artery disease	0.000101	0.000156	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PRKCD—coronary artery disease	0.000101	0.000293	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—coronary artery disease	9.99e-05	0.000292	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—JAK2—coronary artery disease	9.94e-05	0.00029	CbGpPWpGaD
Goserelin—Nausea—Losartan—coronary artery disease	9.94e-05	0.000154	CcSEcCtD
Goserelin—Pruritus—Timolol—coronary artery disease	9.92e-05	0.000154	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EDN1—coronary artery disease	9.92e-05	0.00029	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGB—coronary artery disease	9.86e-05	0.000288	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—coronary artery disease	9.84e-05	0.000287	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2A—coronary artery disease	9.84e-05	0.000287	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—C3—coronary artery disease	9.82e-05	0.000287	CbGpPWpGaD
Goserelin—Diarrhoea—Ramipril—coronary artery disease	9.82e-05	0.000152	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—EDNRB—coronary artery disease	9.76e-05	0.000285	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF1—coronary artery disease	9.7e-05	0.000283	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CSF2—coronary artery disease	9.7e-05	0.000283	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LPL—coronary artery disease	9.63e-05	0.000281	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—THBS1—coronary artery disease	9.61e-05	0.000281	CbGpPWpGaD
Goserelin—Diarrhoea—Timolol—coronary artery disease	9.6e-05	0.000149	CcSEcCtD
Goserelin—Hypersensitivity—Lisinopril—coronary artery disease	9.59e-05	0.000149	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MEF2C—coronary artery disease	9.54e-05	0.000278	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RPS6KB1—coronary artery disease	9.54e-05	0.000278	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PSMA6—coronary artery disease	9.52e-05	0.000278	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PSMB5—coronary artery disease	9.52e-05	0.000278	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—coronary artery disease	9.5e-05	0.000277	CbGpPWpGaD
Goserelin—Dizziness—Ramipril—coronary artery disease	9.49e-05	0.000147	CcSEcCtD
Goserelin—Asthenia—Lisinopril—coronary artery disease	9.34e-05	0.000145	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AGT—coronary artery disease	9.33e-05	0.000272	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGB3—coronary artery disease	9.3e-05	0.000271	CbGpPWpGaD
Goserelin—Dizziness—Timolol—coronary artery disease	9.28e-05	0.000144	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—EDNRA—coronary artery disease	9.21e-05	0.000269	CbGpPWpGaD
Goserelin—Pruritus—Lisinopril—coronary artery disease	9.21e-05	0.000143	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CYBA—coronary artery disease	9.17e-05	0.000268	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB1—coronary artery disease	9.17e-05	0.000268	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DUSP6—coronary artery disease	9.13e-05	0.000267	CbGpPWpGaD
Goserelin—Vomiting—Ramipril—coronary artery disease	9.12e-05	0.000142	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—coronary artery disease	9.08e-05	0.000265	CbGpPWpGaD
Goserelin—Rash—Ramipril—coronary artery disease	9.05e-05	0.00014	CcSEcCtD
Goserelin—Dermatitis—Ramipril—coronary artery disease	9.04e-05	0.00014	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PPP2CA—coronary artery disease	9.03e-05	0.000264	CbGpPWpGaD
Goserelin—Headache—Ramipril—coronary artery disease	8.99e-05	0.000139	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PLAT—coronary artery disease	8.98e-05	0.000262	CbGpPWpGaD
Goserelin—Vomiting—Timolol—coronary artery disease	8.92e-05	0.000138	CcSEcCtD
Goserelin—Diarrhoea—Lisinopril—coronary artery disease	8.9e-05	0.000138	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCD—coronary artery disease	8.87e-05	0.000259	CbGpPWpGaD
Goserelin—Rash—Timolol—coronary artery disease	8.84e-05	0.000137	CcSEcCtD
Goserelin—Dermatitis—Timolol—coronary artery disease	8.84e-05	0.000137	CcSEcCtD
Goserelin—Headache—Timolol—coronary artery disease	8.79e-05	0.000136	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR2A—coronary artery disease	8.68e-05	0.000253	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—C3—coronary artery disease	8.67e-05	0.000253	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL12—coronary artery disease	8.66e-05	0.000253	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB2—coronary artery disease	8.66e-05	0.000253	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—coronary artery disease	8.65e-05	0.000252	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—coronary artery disease	8.62e-05	0.000252	CbGpPWpGaD
Goserelin—Dizziness—Lisinopril—coronary artery disease	8.61e-05	0.000134	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL6ST—coronary artery disease	8.59e-05	0.000251	CbGpPWpGaD
Goserelin—Nausea—Ramipril—coronary artery disease	8.52e-05	0.000132	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—JUNB—coronary artery disease	8.5e-05	0.000248	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLCB1—coronary artery disease	8.47e-05	0.000247	CbGpPWpGaD
Goserelin—Nausea—Timolol—coronary artery disease	8.33e-05	0.000129	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HTR7—coronary artery disease	8.3e-05	0.000242	CbGpPWpGaD
Goserelin—Vomiting—Lisinopril—coronary artery disease	8.27e-05	0.000128	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HIF1A—coronary artery disease	8.27e-05	0.000241	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—coronary artery disease	8.23e-05	0.00024	CbGpPWpGaD
Goserelin—Rash—Lisinopril—coronary artery disease	8.2e-05	0.000127	CcSEcCtD
Goserelin—Dermatitis—Lisinopril—coronary artery disease	8.2e-05	0.000127	CcSEcCtD
Goserelin—Headache—Lisinopril—coronary artery disease	8.15e-05	0.000126	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LEP—coronary artery disease	8.07e-05	0.000236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOE—coronary artery disease	8.07e-05	0.000236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOA1—coronary artery disease	7.98e-05	0.000233	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KDR—coronary artery disease	7.9e-05	0.000231	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ITGAV—coronary artery disease	7.9e-05	0.000231	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KNG1—coronary artery disease	7.88e-05	0.00023	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—POMC—coronary artery disease	7.85e-05	0.000229	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CREB1—coronary artery disease	7.85e-05	0.000229	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK14—coronary artery disease	7.85e-05	0.000229	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGTR1—coronary artery disease	7.83e-05	0.000229	CbGpPWpGaD
Goserelin—Nausea—Lisinopril—coronary artery disease	7.73e-05	0.00012	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ESR1—coronary artery disease	7.7e-05	0.000225	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—coronary artery disease	7.69e-05	0.000224	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6R—coronary artery disease	7.66e-05	0.000224	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL10—coronary artery disease	7.66e-05	0.000223	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLG—coronary artery disease	7.63e-05	0.000223	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—coronary artery disease	7.61e-05	0.000222	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FN1—coronary artery disease	7.61e-05	0.000222	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6ST—coronary artery disease	7.58e-05	0.000221	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NFKBIA—coronary artery disease	7.52e-05	0.000219	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB2—coronary artery disease	7.43e-05	0.000217	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCE—coronary artery disease	7.34e-05	0.000214	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—JAK2—coronary artery disease	7.33e-05	0.000214	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS1—coronary artery disease	7.32e-05	0.000214	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—S100B—coronary artery disease	7.3e-05	0.000213	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KIT—coronary artery disease	7.28e-05	0.000213	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS3—coronary artery disease	7.23e-05	0.000211	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KITLG—coronary artery disease	7.14e-05	0.000209	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFBR2—coronary artery disease	7.14e-05	0.000209	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GSK3B—coronary artery disease	6.99e-05	0.000204	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP3—coronary artery disease	6.98e-05	0.000204	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT5A—coronary artery disease	6.98e-05	0.000204	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—POMC—coronary artery disease	6.93e-05	0.000202	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CREB1—coronary artery disease	6.93e-05	0.000202	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—coronary artery disease	6.78e-05	0.000198	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6R—coronary artery disease	6.76e-05	0.000197	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—coronary artery disease	6.75e-05	0.000197	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—coronary artery disease	6.69e-05	0.000195	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—coronary artery disease	6.67e-05	0.000195	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—JAK2—coronary artery disease	6.66e-05	0.000194	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—coronary artery disease	6.64e-05	0.000194	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAPK1—coronary artery disease	6.64e-05	0.000194	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL5—coronary artery disease	6.59e-05	0.000192	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CSF2—coronary artery disease	6.49e-05	0.000189	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF1—coronary artery disease	6.49e-05	0.000189	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LPL—coronary artery disease	6.44e-05	0.000188	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RPS6KB1—coronary artery disease	6.39e-05	0.000186	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MEF2C—coronary artery disease	6.39e-05	0.000186	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—coronary artery disease	6.34e-05	0.000185	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—coronary artery disease	6.33e-05	0.000185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ITGB3—coronary artery disease	6.22e-05	0.000182	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF2—coronary artery disease	6.13e-05	0.000179	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—coronary artery disease	6.08e-05	0.000177	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPP2CA—coronary artery disease	6.05e-05	0.000176	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—coronary artery disease	6.04e-05	0.000176	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCD—coronary artery disease	5.94e-05	0.000173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAK2—coronary artery disease	5.87e-05	0.000171	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2A—coronary artery disease	5.81e-05	0.00017	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C3—coronary artery disease	5.8e-05	0.000169	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—coronary artery disease	5.76e-05	0.000168	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—coronary artery disease	5.53e-05	0.000162	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—coronary artery disease	5.51e-05	0.000161	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—coronary artery disease	5.4e-05	0.000158	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—coronary artery disease	5.4e-05	0.000158	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—coronary artery disease	5.36e-05	0.000157	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—coronary artery disease	5.34e-05	0.000156	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—coronary artery disease	5.29e-05	0.000154	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK14—coronary artery disease	5.26e-05	0.000153	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—coronary artery disease	5.18e-05	0.000151	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ESR1—coronary artery disease	5.16e-05	0.000151	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—coronary artery disease	5.13e-05	0.00015	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—coronary artery disease	5.1e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—coronary artery disease	5.09e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FN1—coronary artery disease	5.09e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6ST—coronary artery disease	5.07e-05	0.000148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NFKBIA—coronary artery disease	5.03e-05	0.000147	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—coronary artery disease	5e-05	0.000146	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KIT—coronary artery disease	4.87e-05	0.000142	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—coronary artery disease	4.85e-05	0.000142	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—coronary artery disease	4.7e-05	0.000137	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GSK3B—coronary artery disease	4.68e-05	0.000137	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CREB1—coronary artery disease	4.64e-05	0.000135	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—coronary artery disease	4.64e-05	0.000135	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—coronary artery disease	4.54e-05	0.000133	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6R—coronary artery disease	4.53e-05	0.000132	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—coronary artery disease	4.46e-05	0.00013	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK1—coronary artery disease	4.44e-05	0.00013	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—coronary artery disease	4.35e-05	0.000127	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—coronary artery disease	4.24e-05	0.000124	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—coronary artery disease	4.24e-05	0.000124	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF2—coronary artery disease	4.1e-05	0.00012	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—coronary artery disease	4.05e-05	0.000118	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—coronary artery disease	4e-05	0.000117	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JAK2—coronary artery disease	3.93e-05	0.000115	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK1—coronary artery disease	3.92e-05	0.000114	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—coronary artery disease	3.85e-05	0.000113	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—coronary artery disease	3.59e-05	0.000105	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—coronary artery disease	3.47e-05	0.000101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—coronary artery disease	3.44e-05	0.0001	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—coronary artery disease	3.41e-05	9.96e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—coronary artery disease	3.4e-05	9.93e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—coronary artery disease	3.34e-05	9.76e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—coronary artery disease	3.25e-05	9.48e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—coronary artery disease	3.15e-05	9.19e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—coronary artery disease	3.01e-05	8.79e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—coronary artery disease	2.92e-05	8.51e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—coronary artery disease	2.78e-05	8.11e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—coronary artery disease	2.68e-05	7.81e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK1—coronary artery disease	2.62e-05	7.66e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—coronary artery disease	2.28e-05	6.65e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—coronary artery disease	2.02e-05	5.89e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—coronary artery disease	1.86e-05	5.43e-05	CbGpPWpGaD
